T.E.A.M. Feasibility and Efficacy Study 2.0 (TEAM)

• ClinicalTrials.gov Identifier: NCT03694106
• Recruitment Status: Active, not recruiting
• First Posted: October 3, 2018
• Last Update Posted: March 3, 2020
• Sponsor: Feeling Good Institute
• Collaborator: Stanford University
• Information provided by (Responsible Party): Alex Clarke, Feeling Good Institute

Study Description

Brief Summary:

T.E.A.M. psychotherapy was developed by one of the founders of cognitive therapy, David Burns and builds on traditional CBT with an emphasis on T = Testing, E = Empathy, A = Agenda Setting (assessing and building motivation) and M = Methods (including cognitive and behavioral methods). Because TEAM therapy is a data-driven therapy, its delivery hinges on the use of symptom measures and measures of the therapeutic alliance at every session with every patient. These measures are now available for collection thru computerized forms, making their collection and review considerably more accessible and efficient for the patient and therapist.

The following hypotheses will be tested:

1. TEAM psychotherapy using computerized measurement collection is safe and feasible.
2. TEAM psychotherapy using computerized measurement collection shows evidence of efficacy by exploratory non inferiority testing compared to benchmark studies with similar psychotherapeutic modalities
3. Evidence for efficacy is strong enough to justify pursuit of an experimental randomized controlled clinical trial of TEAM therapy for major depressive disorder versus treatment as usual.

Condition or disease	Intervention/treatment
Depression, Anxiety	Behavioral: TEAM PSYCHOTHERAPY

Detailed Description:

A gap currently exists between the technology available for collecting psychotherapy data and the application of this technology to psychotherapeutic settings to enhance treatment outcomes. A novel integration of Cognitive Behavior Therapy (CBT) informed psychotherapy and digitized data collection systems called T.E.A.M. therapy exists that bridges this gap and has yet to be tested. The purpose of this study is to explore whether TEAM CBT appears safe and feasible and has results similar to comparable and similar benchmark studies. This outcome will provide pilot data and a rationale for whether to pursue a separate randomized controlled trial in the future. We will compare the results of TEAM therapy using electronic data collection to similar psychotherapeutic treatments for common psychiatric problems such as depression, anxiety, relationship conflicts and maladaptive behaviors. We will also explore the data for its use in predictive modeling. This study is part of a wider goal of developing best practices in dissemination of standardized measurement based psychotherapies that are effective and use technology via computerized delivery systems guided by therapists. It is hoped that with computer based measurement systems for psychotherapy, more accurate and frequent information for therapists is available to modify earlier and more effectively their approaches. The measurement based systems will also allow performance by psychotherapists to be measured accurately and enable a type of machine based learning environment with feedback systems in place to improve providers' patient care in a more precise and personalized way.

Study Design

• Study Type: Observational
• Estimated Enrollment: 80 participants
• Observational Model: Case-Only
• Time Perspective: Prospective
• Official Title: Feasility Pilot of T.E.A.M. Psychotherapy Using Electronic Capture of Before and After Therapy Measures.
• Actual Study Start Date: April 15, 2019
• Estimated Primary Completion Date: November 1, 2022
• Estimated Study Completion Date: November 1, 2023

Groups and Cohorts

Intervention Details:

• Behavioral: TEAM PSYCHOTHERAPY
  Patients data will be collected from the first to the final psychotherapy session as performed normally by TEAM trained clinicians. The treatment-as-usual includes therapy sessions of 50 to 110minutes long, typically once or twice per week for an average of 8-12 sessions. Treatment as usual by these clinicians includes the use of psychological symptoms survey immediately before and after each psychotherapy session. Typically patients will fill out these surveys in the clinic's waiting area before and after each session.

Outcome Measures

Primary Outcome Measures :

1. NIH PROMIS 4 item depression questionnaire [ Time Frame: 9 months ]

Eligibility Criteria

• Ages Eligible for Study: 18 Years and older (Adult, Older Adult)
• Sexes Eligible for Study: All
• Sampling Method: Non-Probability Sample

Study Population

Receiving TEAM therapy from Level 4 or above therapist.

Criteria

Inclusion Criteria:

• 1. Cognitive functioning at a level and ability to use an electronic tool. 2. Demonstration of decisional capacity in order to participate in psychotherapy.

Exclusion Criteria:

1. Under age 18 3. Providers: not TEAM certified at a level 3 or above 2. Patients: Non-fluent English speakers. The tool for now is only available in English

-

Contacts and Locations

Locations

United States, California

Feeling Good Institute

Mountain View, California, United States, 94040

Sponsors and Collaborators

Feeling Good Institute

Stanford University

Investigators

• Principal Investigator: Maor Katz, MD; Feeling Good Institute
• Principal Investigator: Alex Clarke, MD; Feeling Good Institute

More Information

• Responsible Party: Alex Clarke, Director of Research and Development, Feeling Good Institute
• ClinicalTrials.gov Identifier: NCT03694106
• Other Study ID Numbers: 41809
• First Posted: October 3, 2018
• Last Update Posted: March 3, 2020
• Last Verified: February 2020

Individual Participant Data (IPD) Sharing Statement:

• Plan to Share IPD: Undecided

• Studies a U.S. FDA-regulated Drug Product: No
• Studies a U.S. FDA-regulated Device Product: No

Additional relevant MeSH terms:

Depression; Behavioral Symptoms